Compare MMYT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MMYT | PEN |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | India | United States |
| Employees | 5122 | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 10.9B |
| IPO Year | 2010 | 2015 |
| Metric | MMYT | PEN |
|---|---|---|
| Price | $73.51 | $299.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 16 |
| Target Price | $120.00 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 823.9K | 479.9K |
| Earning Date | 01-22-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | 0.69 | ★ 4.14 |
| Revenue | $1,011,011,000.00 | ★ $1,333,798,000.00 |
| Revenue This Year | $19.90 | $16.77 |
| Revenue Next Year | $19.52 | $14.12 |
| P/E Ratio | $107.05 | ★ $72.65 |
| Revenue Growth | 14.55 | ★ 14.61 |
| 52 Week Low | $70.10 | $221.26 |
| 52 Week High | $123.00 | $310.00 |
| Indicator | MMYT | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 40.45 | 67.77 |
| Support Level | $70.75 | $284.95 |
| Resistance Level | $75.72 | $298.69 |
| Average True Range (ATR) | 2.58 | 8.02 |
| MACD | 0.69 | 0.11 |
| Stochastic Oscillator | 43.26 | 91.50 |
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.